NCT06729463 IKBKB Gene Polymorphism (Single Nucleotide Polymorphism) (SNP) in Psoriatic and Psoriatic Arthritis Patients Status COMPLETED Phase NA
NCT06005532 Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira® Status RECRUITING Phase PHASE3
NCT05683626 Safety and Efficacy of Adalimumab Therapy for Treatment of Behcet's Disease-related Uveitis in Sohag University Hospital Status UNKNOWN Phase N/A
NCT04135508 A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira Status COMPLETED Phase PHASE3
NCT02871635 BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity Status COMPLETED Phase PHASE3
NCT02850965 Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT02581345 Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis Status COMPLETED Phase PHASE3
NCT02451748 IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA Status COMPLETED Phase PHASE4
NCT02206867 Pharmacokinetics and Safety Study of LBAL in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00731757 Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis Status WITHDRAWN Phase PHASE2
NCT00730717 Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum Status WITHDRAWN Phase PHASE2